ArticleBreast cancer research and treatment2026

Refined risk stratification in residual triple-negative breast cancer after neoadjuvant therapy using residual cancer burden class and lymphovascular invasion.

Tae Hoon Lee et al.PubMed ↗Full text ↗Publisher ↗

No numbers read from the abstract.